Correlation Between BigBearai Holdings and Recursion Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BigBearai Holdings and Recursion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BigBearai Holdings and Recursion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BigBearai Holdings and Recursion Pharmaceuticals, you can compare the effects of market volatilities on BigBearai Holdings and Recursion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BigBearai Holdings with a short position of Recursion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of BigBearai Holdings and Recursion Pharmaceuticals.

Diversification Opportunities for BigBearai Holdings and Recursion Pharmaceuticals

0.45
  Correlation Coefficient

Very weak diversification

The 3 months correlation between BigBearai and Recursion is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding BigBearai Holdings and Recursion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Recursion Pharmaceuticals and BigBearai Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BigBearai Holdings are associated (or correlated) with Recursion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Recursion Pharmaceuticals has no effect on the direction of BigBearai Holdings i.e., BigBearai Holdings and Recursion Pharmaceuticals go up and down completely randomly.

Pair Corralation between BigBearai Holdings and Recursion Pharmaceuticals

Given the investment horizon of 90 days BigBearai Holdings is expected to generate 1.42 times more return on investment than Recursion Pharmaceuticals. However, BigBearai Holdings is 1.42 times more volatile than Recursion Pharmaceuticals. It trades about 0.18 of its potential returns per unit of risk. Recursion Pharmaceuticals is currently generating about 0.07 per unit of risk. If you would invest  155.00  in BigBearai Holdings on September 12, 2024 and sell it today you would earn a total of  156.00  from holding BigBearai Holdings or generate 100.65% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

BigBearai Holdings  vs.  Recursion Pharmaceuticals

 Performance 
       Timeline  
BigBearai Holdings 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in BigBearai Holdings are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady basic indicators, BigBearai Holdings demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Recursion Pharmaceuticals 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Recursion Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Recursion Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

BigBearai Holdings and Recursion Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BigBearai Holdings and Recursion Pharmaceuticals

The main advantage of trading using opposite BigBearai Holdings and Recursion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BigBearai Holdings position performs unexpectedly, Recursion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Recursion Pharmaceuticals will offset losses from the drop in Recursion Pharmaceuticals' long position.
The idea behind BigBearai Holdings and Recursion Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
FinTech Suite
Use AI to screen and filter profitable investment opportunities